The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
Authors
Keywords
Prostate cancer, Prognostic prediction, Cancer-specific mortality, Cambridge Prognostic Groups, Non-metastatic disease, Stratification, All-cause mortality, Competing risks, Improved treatment section, Treatment selection
Journal
BMC Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-28
DOI
10.1186/s12916-018-1019-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Genomic hallmarks of localized, non-indolent prostate cancer
- (2017) Michael Fraser et al. NATURE
- Prostate Cancer, Version 2.2014
- (2017) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden
- (2016) Katarina Tomic et al. ACTA ONCOLOGICA
- Successful external validation of a model to predict other cause mortality in localized prostate cancer
- (2016) Matthew Kent et al. BMC Medicine
- Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer
- (2016) David Thurtle et al. BRITISH JOURNAL OF CANCER
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
- (2016) Hima Bindu Musunuru et al. JOURNAL OF UROLOGY
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The very-high-risk prostate cancer: a contemporary update
- (2016) R Mano et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
- (2016) Amar S. Ahmad et al. Oncotarget
- Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study
- (2016) Vincent J. Gnanapragasam et al. PLOS MEDICINE
- On Risk Estimation versus Risk Stratification in Early Prostate Cancer
- (2016) Sigrid V. Carlsson et al. PLOS MEDICINE
- Prostate cancer in East Asia: evolving trend over the last decade
- (2015) Ding-Wei Ye et al. ASIAN JOURNAL OF ANDROLOGY
- Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades
- (2015) Nicola Fossati et al. BJU INTERNATIONAL
- Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study
- (2015) Steven Joniau et al. EUROPEAN UROLOGY
- Definition and Validation of “Favorable High-Risk Prostate Cancer”: Implications for Personalizing Treatment of Radiation-Managed Patients
- (2015) Vinayak Muralidhar et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Urologic cancer in Thailand
- (2015) Bannakij Lojanapiwat JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Risk Group and Death From Prostate Cancer
- (2015) Ann C. Raldow et al. JAMA Oncology
- Trends and Outcome from Radical Therapy for Primary Non-Metastatic Prostate Cancer in a UK Population
- (2015) David C. Greenberg et al. PLoS One
- Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial
- (2014) Andrea Guttilla et al. Radiation Oncology
- Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI–TRUS fusion techniques
- (2014) Timur H. Kuru et al. WORLD JOURNAL OF UROLOGY
- Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
- (2013) Sue M Evans et al. MEDICAL JOURNAL OF AUSTRALIA
- Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy
- (2013) Adam W. Nelson et al. PLoS One
- Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
- (2012) M. Van Hemelrijck et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The emerging role of diffusion-weighted MRI in prostate cancer management
- (2012) Edward M. Lawrence et al. Nature Reviews Urology
- Cancer incidence in the United Kingdom: projections to the year 2030
- (2011) M Mistry et al. BRITISH JOURNAL OF CANCER
- Inaccuracies in assignment of clinical stage for localized prostate cancer
- (2010) Adam C. Reese et al. CANCER
- Reliability of death certificates in prostate cancer patients
- (2008) Katja Fall et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started